Gaurav Shah insider trades: Rocket Pharmaceuticals (RCKT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gaurav reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | RCKT | ↓ Sell | 2,293 | $3.38 | $8K | Direct | Aug 20, 2026 (2d) |
| Aug 13, 2026 | RCKT | ↓ Sell | 2,837 | $3.38 | $10K | Direct | Aug 17, 2026 (4d) |
| May 21, 2026 | RCKT | ↓ Sell | 55,684 | $3.09 | $172K | Direct | May 26, 2026 (5d) |
| May 19, 2026 | RCKT | ↓ Sell | 2,409 | $3.01 | $7K | Direct | May 21, 2026 (2d) |
| May 13, 2026 | RCKT | ↓ Sell | 2,728 | $3.61 | $10K | Direct | May 14, 2026 (1d) |
| Feb 18, 2026 | RCKT | ↓ Sell | 5,990 | $3.34 | $20K | Direct | Feb 20, 2026 (2d) |
| Feb 13, 2026 | RCKT | ↓ Sell | 12,279 | $3.31 | $41K | Direct | Feb 18, 2026 (5d) |
| Nov 18, 2025 | RCKT | ↓ Sell | 6,276 | $2.98 | $19K | Direct | Nov 20, 2025 (2d) |
| May 20, 2025 | RCKT | ↓ Sell | 2,253 | $6.45 | $15K | Direct | May 22, 2025 (2d) |
| May 16, 2025 | RCKT | ↓ Sell | 3,621 | $6.53 | $24K | Direct | May 20, 2025 (4d) |
| Apr 10, 2025 | RCKT | ↑ Buy | 20,000 | $5.08 | $102K | Direct | Apr 14, 2025 (4d) |
| Feb 21, 2025 | RCKT | ↓ Sell | 16,303 | $10.58 | $172K | Direct | Feb 25, 2025 (4d) |
| Nov 21, 2024 | RCKT | ↓ Sell | 11,091 | $13.05 | $145K | Direct | Nov 25, 2024 (4d) |
| Aug 16, 2024 | RCKT | ↓ Sell | 9,650 | $18.50 | $179K | Direct | Aug 20, 2024 (4d) |
| May 16, 2024 | RCKT | ↓ Sell | 9,790 | $23.35 | $229K | Direct | May 20, 2024 (4d) |
| Feb 16, 2024 | RCKT | ↓ Sell | 20,272 | $29.84 | $605K | Direct | Feb 21, 2024 (5d) |
| Aug 17, 2023 | RCKT | ↓ Sell | 4,767 | $15.47 | $74K | Direct | Aug 21, 2023 (4d) |
| May 17, 2023 | RCKT | ↓ Sell | 4,122 | $21.38 | $88K | Direct | May 19, 2023 (2d) |
| Feb 17, 2023 | RCKT | ↓ Sell | 12,194 | $19.06 | $232K | Direct | Feb 22, 2023 (5d) |
| Feb 7, 2022 | RCKT | ↑ Buy | 22,000 | $17.34 | $382K | Direct | Feb 8, 2022 (1d) |
| Mar 5, 2019 | RCKT | ↓ Sell10b5-1 | 74,900 | $17.17 | $1.3M | Direct | Mar 5, 2019 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RCKT insiders
Open-market trades in the last 12 months
About Gaurav Shah's insider trades
Gaurav Shah is CEO at Rocket Pharmaceuticals (RCKT). Since Mar 5, 2019, Gaurav has reported 2 open-market purchases worth $483K and 19 sales worth $3.3M on SEC Form 4. In the last 12 months: 8 sales ($286K).
1 sale (39% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (10 filings), option exercises (9 filings), shares withheld for taxes (5 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RCKT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.